Published in Hospital Business Week, February 27th, 2005
"Progress in stem cell biology research is enhancing our ability to generate specific neuron types for basic and applied studies and to design new treatments for neurodegenerative diseases.
"In the case of Parkinson's disease (PD), alternative human dopaminergic (DAergic) neurons other than primary fetal tissue do not yet exist. One possible source could behumanneural stem cells (hNSCs), although the yield in DAergic neurons and their survival are very limited," investigators in Spain report.
"In this study," I. Liste and coworkers wrote, "we found that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.